All news updates:

Laurens de Vries supports the HERAN team in focussing on investment opportunities and mapping market segments, in order to actively source innovative ventures.

HERAN Partners invests in Broken String Biosciences: a genomics company building a technology platform to drive the development of cell and gene therapies.

Thirona raises EUR 7,5m in new financing round to accelerate the adoption of its breakthrough innovations for precision medicine

New CEO Mark Truesdale will bring the disruptive technology of FOx Biosystems to a wider audience and ensure its further success

HERAN Partners co-leads the GBP 6,5M financing round of Hypervision Surgical: a London-based venture building an advanced surgical imaging and data analytics platform.

We take a look behind the scenes of an ambitious start-up and investors in the HealthTech field by going into conversation with Thomas Van Elzakker, CEO of FOx Biosystems and Katleen Vandersmissen, Managing Partner at HERAN Partners.

HERAN Partners is pleased to announce its investment in ImmuneSpec, a Company at the forefront of advanced immunopeptidomics. The EUR 1,2m seed funding from HERAN HealthTech Fund I will enable ImmuneSpec to accelerate the further optimisation and commercial roll-out of their advanced immunopeptidomics analysis platform.

Want to make your SME or start-up more sustainable, but don't have the resources for a sustainability manager? During a recent double interview with Trends magazine, Charlotte Vandierendonck of the consulting firm Studio D and HERAN Partners managing director Katleen Vandersmissen answered six questions to help you get started.

The additional raised capital will be used to scale up the company’s operations, accelerate the development of new application areas and further boost commercialization.